Outcomes of Treat-and-Extend versus Pro Re Nata Anti-VEGF Injections for Myopic Macular Neovascularization in Patients in the United States

被引：0
作者：
Swaminathan, Shreya [1 ]
Mahmoudzadeh, Raziyeh [2 ]
Wakabayashi, Taku [2 ]
Bowers, Mallory Elva [1 ]
Abishek, Robert [2 ]
Salabati, Mirataollah [2 ]
Hsu, Jason [2 ]
Dunn, James P. [2 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
[41]   Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis [J].
Rosenberg, Daniel ;
Deonarain, Deven M. ;
Gould, Jonah ;
Sothivannan, Amirthan ;
Phillips, Mark R. ;
Sarohia, Gurkaran S. ;
Sivaprasad, Sobha ;
Wykoff, Charles C. ;
Cheung, Chui Ming Gemmy ;
Sarraf, David ;
Bakri, Sophie J. ;
Chaudhary, Varun .
EYE, 2023, 37 (01) :6-16
[42]   Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis [J].
Daniel Rosenberg ;
Deven M. Deonarain ;
Jonah Gould ;
Amirthan Sothivannan ;
Mark R. Phillips ;
Gurkaran S. Sarohia ;
Sobha Sivaprasad ;
Charles C. Wykoff ;
Chui Ming Gemmy Cheung ;
David Sarraf ;
Sophie J. Bakri ;
Varun Chaudhary .
Eye, 2023, 37 :6-16
[43]   One-Year Results of Using a Treat-and-Extend Regimen without a Loading Phase with Anti-VEGF Agents in Patients with Treatment-Naive Diabetic Macular Edema [J].
Schwarzer, Petra ;
Ebneter, Andreas ;
Munk, Marion ;
Wolf, Sebastian ;
Zinkernagel, Martin S. .
OPHTHALMOLOGICA, 2019, 241 (04) :220-225
[44]   To investigate treat and extend versus pro re nata regimen in neovascular age-related macular degeneration: results from the IDEM study [J].
Faudi, Emilien ;
Gauthier, Anne-Sophie ;
Delbosc, Bernard ;
Saleh, Maher .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) :2149-2156
[45]   To investigate treat and extend versus pro re nata regimen in neovascular age-related macular degeneration: results from the IDEM study [J].
Emilien Faudi ;
Anne-Sophie Gauthier ;
Bernard Delbosc ;
Maher Saleh .
Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 :2149-2156
[46]   Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment [J].
Giacomelli, Giovanni ;
Finocchio, Lucia ;
Biagini, Ilaria ;
Sodi, Andrea ;
Murro, Vittoria ;
Introini, Ugo ;
Varano, Monica ;
Bandello, Francesco ;
Menchini, Ugo .
OPHTHALMOLOGICA, 2017, 238 (1-2) :44-51
[47]   Switching the Treatment Regime from PRN (pro re nata, as needed) to T&E (Treat and Extend) for Intravitreal Therapy with Anti-VEGF Agents in Private Practice or Small Institutions [J].
Imesch, P. ;
Sarra, G. -M. .
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (01) :39-46
[48]   Treat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study [J].
Hatz, Katja ;
Prunte, Christian .
ACTA OPHTHALMOLOGICA, 2017, 95 (01) :E67-E72
[49]   Anti-VEGF injection patterns and five year functional outcomes in patients with choroidal neovascularization or macular edema [J].
Wecker, Thomas ;
Ehiken, Christoph ;
Buehler, Anima ;
Lange, Clemens ;
Agostini, Hansjuergen ;
Boehringer, Daniel ;
Stahl, Andreas .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[50]   Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen [J].
Spooner, Kimberly L. ;
Fraser-Bell, Samantha ;
Cozzi, Mariano ;
Staurenghi, Giovanni ;
Invernizzi, Alessandro ;
Monteduro, Davide ;
Munk, Marion R. ;
Hong, Thomas ;
Chang, Andrew A. .
OPHTHALMOLOGY, 2020, 127 (12) :1663-1673
12345